Your browser doesn't support javascript.
Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies.
Li, Ying; Liu, Shanglong; Zhang, Shuchao; Ju, Qiang; Zhang, Shaoqiang; Yang, Yuanming; Wang, Haiyan.
  • Li Y; Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Liu S; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
  • Zhang S; Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Ju Q; Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Zhang S; Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Yang Y; Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Wang H; Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Electronic address: why_phd@163.com.
Transfus Apher Sci ; 59(5): 102839, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-506054
ABSTRACT
COVID-19 is caused by SARS-CoV-2 which is a new enveloped virus that belongs to the Beta coronavirus genus. As a major health crisis, SARS-CoV-2 has infected over a million people around the world. There is currently no specific treatment available for patients with COVID-19 infection. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been used in clinical practice. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and discusses the clinical value of blood transfusion-related technologies used in COVID-19 treatment.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Component Transfusion / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Transfus Apher Sci Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: J.transci.2020.102839

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Component Transfusion / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Transfus Apher Sci Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: J.transci.2020.102839